HCM
BMRN icon

Holland Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Holland Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-742,210
Closed -$46.2M – 71
2014
Q2 		$46.2M Sell
742,210
-880,514
-54% -$53.2M 0.98% 44
2014
Q1 		$111M Sell
1,622,724
-59,260
-4% -$4.37M 2.4% 12
2013
Q4 		$118M Buy
1,681,984
+599,012
+55% +$40.7M 2.45% 11
2013
Q3 		$78.2M Buy
1,082,972
+28,417
+3% +$1.89M 1.81% 26
2013
Q2 		$58.8M Buy
+1,054,555
New +$65.7M 1.48% 32

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Holland Capital Management's BMRN Position: Q3 2014 in Review

Holland Capital Management sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2014, closing a stake of 742,210 shares — an estimated $46.2M sold.

Holland Capital Management first reported a position in BMRN in Q2 2013 and held it in 5 quarters. The position peaked at $118M in Q4 2013. 317 funds tracked by Wall St. Rank hold BMRN as of Q3 2014.

  • Holland Capital Management reported no remaining BioMarin Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Holland Capital Management sold 742,210 BioMarin Pharmaceuticals shares in Q3 2014, an estimated $46.2M.
  • Holland Capital Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Holland Capital Management's BioMarin Pharmaceuticals position peaked at $118M in Q4 2013.
  • 317 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2014.

Based on Holland Capital Management's 13F filing for Q3 2014, filed 30 Oct 2014.